Table 4.
Analysis of ANOVA Results
| Creator Type (M ± SD) | F | p | ||||
|---|---|---|---|---|---|---|
| Individuals (n=75) | Medical Workers (n=30) | Media (n=92) | Corporate Companies (n=5) | |||
| The richness of Vaccine knowledge | 2.19±1.70 | 2.03±1.40 | 1.85±1.58 | 2.60±1.14 | 0.855 | 0.465 |
| The richness of Vaccine issues | 1.69±1.28 | 1.60±1.28 | 1.53±1.10 | 0.80±0.84 | 0.985 | 0.401 |
| Vaccine attitude | 3.83±1.28 | 4.20±1.00 | 3.93±1.31 | 4.20±1.10 | 0.709 | 0.547 |
| Communication breadth | 1.89±1.07 | 2.28±0.97 | 2.49±0.80 | 1.99±0.89 | 5.913 | 0.001** |
| Communication recognition | 3.98±1.01 | 3.84±0.96 | 4.45±0.60 | 3.63±1.09 | 7.012 | 0.000** |
| Communication participation | 2.07±0.94 | 2.01±0.89 | 2.47±0.59 | 1.44±1.22 | 6.274 | 0.000** |
Note: **p<0.01.